Travere Therapeutics, Inc. TVTX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s cash ratio?
- Travere Therapeutics, Inc. (TVTX) reported cash ratio of 0.6× in Q1 2026.
- How has Travere Therapeutics, Inc.'s cash ratio changed year-over-year?
- Travere Therapeutics, Inc.'s cash ratio increased by 84.2% year-over-year, from 0.3× to 0.6×.
- What is the long-term trend for Travere Therapeutics, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s cash ratio has grown at a -8.7% compound annual growth rate (CAGR), from 0.9× to 0.6×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.